問卷

TPIDB > Principal Investigator

Principal Investigator


Taichung Veterans General Hospital

Division of Obstetrics & Gynecology

更新時間:2025-10-18

孫洛
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2024-12-01 - 2028-12-31

Phase III

Active
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
  • Condition/Disease

    p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

  • Test Drug

    tablet

Participate Sites
7Sites

Recruiting7Sites